Pasithea Therapeutics Corp.
KTTA
$0.57
-$0.03-4.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -41.92% | 19.47% | -218.18% | -1.25% | 3.88% |
| Total Depreciation and Amortization | -2.23% | -3.02% | -2.96% | 11.89% | -0.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 365.11% | -4,954.67% | 3,889.57% | -50.05% | -66.17% |
| Change in Net Operating Assets | 126.16% | -312.55% | -124.44% | 71.42% | 28.43% |
| Cash from Operations | -21.68% | -56.66% | -120.91% | 7.39% | 4.21% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.85% | -99.95% | 18,820,200.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -64.44% | -102.56% | -- |
| Cash from Financing | -99.85% | -99.95% | 239,174.58% | -102.56% | -- |
| Foreign Exchange rate Adjustments | -766.07% | -- | -98.22% | 146.86% | 293.10% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -352.50% | -200.87% | 2,193.02% | -314.80% | 146.41% |